Lakefront Biotherapeutics Stock (NASDAQ:LKFT)
Previous Close
$29.38
52W Range
$25.68 - $37.78
50D Avg
$28.27
200D Avg
$30.19
Market Cap
$1.97B
Avg Vol (3M)
$251.23K
Beta
0.12
Div Yield
-
LKFT Company Profile
Lakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scientific innovation. It is dedicated to building a pipeline of medicines for patients with serious diseases in therapeutic areas of unmet need, prioritizing oncology and immunology & inflammation programs. The company's clinical-stage portfolio is anchored by potential first-in-class treatments for autoimmune diseases.